S
Steven K. Herrine
Researcher at Thomas Jefferson University
Publications - 73
Citations - 2843
Steven K. Herrine is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Hepatitis C & Ribavirin. The author has an hindex of 23, co-authored 71 publications receiving 2596 citations. Previous affiliations of Steven K. Herrine include Thomas Jefferson University Hospital.
Papers
More filters
Journal ArticleDOI
The Devil is in the Third Year: A Longitudinal Study of Erosion of Empathy in Medical School
Mohammadreza Hojat,Michael J. Vergare,Kaye Maxwell,George C. Brainard,Steven K. Herrine,Gerald A. Isenberg,John Veloski,Joseph S. Gonnella +7 more
TL;DR: It is concluded that a significant decline in empathy occurs during the third year of medical school, and it is ironic that the erosion of empathy occurs when the curriculum is shifting toward patient-care activities; this is when empathy is most essential.
Journal ArticleDOI
Effects of antiviral therapy on the cellular immune response in acute hepatitis C
Fareed Rahman,Theo Heller,Yuji Sobao,Eishiro Mizukoshi,Michelina Nascimbeni,Harvey J. Alter,Steven K. Herrine,Jay H. Hoofnagle,T. Jake Liang,Barbara Rehermann +9 more
TL;DR: A sustained response to antiviral therapy was not associated with a lasting enhancement of HCV‐specific T‐cell responsiveness in the blood, as previously reported.
Journal ArticleDOI
Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate
Mark S. Sulkowski,Mitchell L. Shiffman,Nezam H. Afdhal,K. Rajender Reddy,Jonathan McCone,William M. Lee,Steven K. Herrine,Stephen A. Harrison,Fred Poordad,Kenneth Koury,W. Deng,Stephanie Noviello,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,John G. McHutchison +15 more
TL;DR: Among HCV genotype 1-infected patients treated with PEG-IFN/RBV, anemia was associated with higher rates of sustained virologic responses (SVR), and the effect of ESAs varied by time to anemia; patients with early-onset anemia hadHigher rates of SVR with ESA use, whereas no effect was observed in those with late-onsets anemia.
Journal ArticleDOI
Pregnancy after liver transplantation
TL;DR: Pregnancy in the setting of recurrent liver disease, such as recurrent hepatitis C, poses a potential problem among liver transplant recipients, as well as the possible adverse effects of immunosuppression on maternal kidney function.
Journal ArticleDOI
The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database
TL;DR: A careful examination of the OPTN database, with respect to HLA match or mismatch and liver graft survival, reaffirms that HLA matching has no clinically significant impact on this outcome.